Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A massive analysis recently published in the journal Aging Cell revealed that rapamycin — the immunosuppressant drug turned ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

A daily medication relied on by more than half a million women is under urgent recall after a critical test failure raised ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.